Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
1.485
-0.055 (-3.57%)
At close: Aug 28, 2026, 4:00 PM EDT
1.620
+0.135 (9.08%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Aldeyra Therapeutics Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Aldeyra Therapeutics stock has a consensus rating of "Buy" and an average price target of $6.60. The average 1-year stock price forecast is 344.44% higher than the current stock price, while the lowest is $2.00 (+34.68%) and the highest is $13 (+775.42%).
Price Target: $6.60 (+344.44%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Aldeyra Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 3 | 3 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates $2 | Hold | Reiterates | $2 | +34.68% | Aug 17, 2026 |
| BTIG | BTIG | Buy Maintains $9 | Buy | Maintains | $9 | +506.06% | Mar 18, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
6.72M
EPS This Year
-0.34
from -0.56
EPS Next Year
-0.28
from -0.34
EPS and Forward PE are based on non-GAAP adjusted numbers.